Rakesh Srivastava

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. ncbi Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
    Sanjit K Roy
    Department of Pathology and Laboratory Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    J Mol Signal 5:10. 2010
  2. ncbi The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
    Su Ni Tang
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    J Mol Signal 5:14. 2010
  3. ncbi Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells
    Rakesh K Srivastava
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS 66160, USA
    Front Biosci (Elite Ed) 3:515-28. 2011

Research Grants

  1. Chemoprevention of Pancreatic Cancer by EGCG
    Rakesh K Srivastava; Fiscal Year: 2009
  2. Chemoprevention of Pancreatic Cancer by EGCG
    Rakesh K Srivastava; Fiscal Year: 2010
  3. Mechanisms of Chemoprevention by Resveratrol
    Rakesh Srivastava; Fiscal Year: 2009
  4. Chemoprevention of Pancreatic Cancer by EGCG
    Rakesh K Srivastava; Fiscal Year: 2009

Collaborators

  • Sanjit K Roy
  • Su Ni Tang
  • Sharmila Shankar
  • Chandan Singh
  • Daniel Meeker
  • Dara Nall

Detail Information

Publications3

  1. ncbi Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
    Sanjit K Roy
    Department of Pathology and Laboratory Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    J Mol Signal 5:10. 2010
    ....
  2. ncbi The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
    Su Ni Tang
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    J Mol Signal 5:14. 2010
    ....
  3. ncbi Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells
    Rakesh K Srivastava
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS 66160, USA
    Front Biosci (Elite Ed) 3:515-28. 2011
    ..These data suggest that SFN either alone or in combination with quercetin can eliminate cancer stem cell-characteristics...

Research Grants10

  1. Chemoprevention of Pancreatic Cancer by EGCG
    Rakesh K Srivastava; Fiscal Year: 2009
    ....
  2. Chemoprevention of Pancreatic Cancer by EGCG
    Rakesh K Srivastava; Fiscal Year: 2010
    ....
  3. Mechanisms of Chemoprevention by Resveratrol
    Rakesh Srivastava; Fiscal Year: 2009
    ..Thus, resveratrol based strategies can be utilized for prevention and treatment of prostate cancer, and in the long-term it may have profound impact on the overall incidence of human prostate cancer. ..
  4. Chemoprevention of Pancreatic Cancer by EGCG
    Rakesh K Srivastava; Fiscal Year: 2009
    ....